Citation:Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, et al 2007

Citation

Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 2007 Aug 1;25(22):3230-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17664471.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Molecular pathology and biomarkers – implications for systemic therapy